By Jeff Rose Zacks cut shares of Histogenics Corp (NASDAQ:HSGX)from a hold rating to a sell rating in a research reportsent to investors…
Read More »By Karim Khaledi Histogenics Corp (NASDAQ:HSGX) was downgraded by Zacks from a “hold” rating to a “sell” rating in a report released on…
Read More »